Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis. (Q53665609)

17 May 2018

title

Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis. (English)

1 reference

17 May 2018

1 reference

Piccoli A

1

1 reference

17 May 2018

Pillon L

series ordinal

2

1 reference

17 May 2018

Passerini P

series ordinal

3

1 reference

17 May 2018

Ponticelli C

series ordinal

4

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 April 1994

1 reference

17 May 2018

published in

Kidney International

1 reference

17 May 2018

volume

45

1 reference

17 May 2018

page(s)

1193-1202

1 reference

17 May 2018

issue

4

1 reference

17 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1994.158

exact match

0 references

cites work

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Is renal biopsy necessary for optimal management of the idiopathic nephrotic syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Idiopathic nephrotic syndrome. Puncturing the biopsy myth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Cost-effective care of end-stage renal disease: a billion dollar question

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1994.158

1 reference

7 January 2021

Prognosis and treatment of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Treatment of Membranous Glomerulonephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Treatment of proteinuric idiopathic glomerulonephritides in adults: a retrospective survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

NIH conference. Membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.158

7 January 2021

Identifiers

DOI

10.1038/KI.1994.158

1 reference

17 May 2018

Dimensions Publication ID

0 references

1 reference

17 May 2018